Expensive Cancer Drugs From Gilead and Novartis Losing Patients to Experimental Treatments

Expensive Cancer Drugs From Gilead and Novartis Losing Patients to Experimental Treatments

Large numbers of U.S. lymphoma patients are opting into experimental treatments in clinical trials versus expensive cell therapies sold by Gilead and Novartis, new...
Dollars with stethoscope on them. Costs for the medical insurance.

$3+ Billion Revenue TRUVADA and the Interesting Patent Question Few Knew About

The price of drugs becomes more contentious as some classes of drugs increase in price far faster than prevailing incomes. This overall trend appears...
Asian business man analyze and discuss the situation on the marketing data online and calculate about cost in the meeting room. Business finances and accounting

ICER Analysis Points out Novartis Mayzent Too High

ICER found that tiprotimod (Mayzent) reduced the risk of multiple sclerosis progression as well as decreased inflammatory disease activities however it’s analysis reveals the...
Oncology

FDA Approves Pfizer’s Biosimilar, Zirabev, to Roche’s Avastin

The FDA has approved bevacizumab-bvxr (Zirabev, Pfizer), a biosimilar to bevacizumab (Avastin, Genentech/Roche), for the treatment of five types of cancer. These cancers include...
Elderly Discrimination

Does ICER Promote Discriminatory Drug Pricing Based on Its Analytics Methods?

A nonprofit known as Alliance for Aging Research has put out a fact sheet suggesting ICER research analytics be questioned on grounds that it...
Pricing of Cancer Medicines

WHO: Pricing of Cancer Medicines and It’s Impacts

WHO, a World Health Organization that examines pricing approaches adopted by the pharmaceutical industry and authorities responsible for the pricing of medicines, has a...
Germany’s model of negotiating drug prices

Should the United States Adopt Germany’s Model of Negotiating Drug Prices?

Germany’s approach to negotiating drug prices demonstrates that a balanced result can be achieved when patients don’t lose drug access or choice options and...
The phychiatrist prescribing man with medical depression

ICER Final Report on Spravato Puts in the ‘Low Value for Money’ Category for...

Janssen (J&J) Esketamine recently was approved as an antidepressant by the FDA. Called Spravato, the original cat tranquilizer was used for off-label treatment of...
Panorama of caregiver supporting sleeping sick child with cancer in the hospice

Why do 11 Cancer Centers Get to Charge More than Other Elite Hospitals and...

Eleven cancer centers have been allowed by the U.S government to charge higher fees for their care than other centers.  A new study identifies...